How Long Should a SARM Cycle Be: Timing by Compound

Most SARM cycles run between 6 and 12 weeks, depending on the specific compound and your experience level. Shorter cycles carry less risk of hormonal suppression and organ stress, while longer cycles push closer to the point of diminishing returns and increasing side effects. The right length for you depends on which SARM you’re using, how your body responds, and whether you’re stacking multiple compounds.

Before going further: SARMs are not FDA-approved for human use. They cannot legally be sold as dietary supplements or drugs in the United States. The FDA has issued repeated warnings linking SARMs to liver injury, heart attack, stroke, infertility, and other serious health problems. What follows is an evidence-based breakdown of how these compounds are actually used, not an endorsement of that use.

Cycle Length by Compound

Different SARMs have different potency profiles, and cycle length reflects that. More suppressive compounds generally call for shorter cycles.

LGD-4033 (Ligandrol) is typically run for 6 to 8 weeks. Beginners often start at 6 weeks, while intermediate users extend to 8. Even advanced users rarely push beyond 8 weeks. A controlled study found that LGD-4033 significantly suppressed free testosterone at just 1 mg per day over 3 weeks, which is why shorter cycles are preferred. Typical lean mass gains fall in the range of 4 to 7 pounds over a 6 to 8 week cycle.

RAD-140 (Testolone) cycles tend to run slightly longer. Beginners usually start with 8 weeks, intermediate users run 8 to 10, and advanced users sometimes extend to 10 or 12 weeks. Users typically report 6 to 10 pounds of lean mass over an 8 to 12 week cycle. When stacking RAD-140 with other compounds, keeping the cycle to 8 to 10 weeks is the general recommendation.

Ostarine (MK-2866) is considered the mildest of the three and is commonly run for 8 to 12 weeks. Its lighter suppressive profile is the reason users feel comfortable with longer durations, though anecdotal reports and clinical observations still show testosterone suppression at higher doses over extended periods.

Why Longer Isn’t Better

There’s a biological ceiling to how long a cycle remains productive. Primate research shows that measurable increases in body weight from a SARM took about 4 weeks of daily dosing to appear, with peak plasma levels stabilizing within the first 2 weeks. This means the compound reaches full working concentration quickly, and the muscle-building window opens early in the cycle.

The problem with extending beyond that productive window is that suppression deepens with every additional week. Your body’s natural testosterone production drops further, your liver takes more cumulative stress, and your lipid profile continues to deteriorate. The gains per week slow down, but the side effects per week keep climbing. This is why even aggressive users rarely exceed 12 weeks on any single SARM.

Signs You Should End a Cycle Early

Certain symptoms warrant stopping immediately, regardless of where you are in your planned cycle. Yellowing of the skin or eyes (jaundice), dark or brown urine, persistent nausea, severe fatigue, upper abdominal pain, and unexplained itching are all associated with drug-induced liver injury from SARMs. In published case reports, liver enzyme levels in affected users reached nearly three times the normal upper limit.

One important detail from the medical literature: in several documented cases, patients didn’t develop symptoms while actively taking the SARM. The liver damage became apparent only after stopping, sometimes within days and sometimes up to 3 weeks later. This means feeling fine during a cycle is not a reliable indicator that your liver is fine. If you’re going to use these compounds, getting bloodwork during and after the cycle is the only way to catch problems early.

Shortness of breath is another red flag. At least one case of acute myocarditis (inflammation of the heart muscle) has been reported in connection with SARM use. Blurred vision, extreme thirst, and frequent urination have also appeared in adverse event reports.

Post Cycle Therapy and Recovery

After finishing a SARM cycle, most users run post cycle therapy (PCT) to help restore natural testosterone production. The typical protocol starts 3 to 5 days after the last dose, since oral compounds clear the body quickly. A standard PCT lasts 4 to 6 weeks.

Here’s the part many people underestimate: the recovery period between cycles matters as much as the cycle itself. A widely followed rule is that your time off should equal your time on plus the length of your PCT. So an 8-week cycle followed by 4 weeks of PCT means waiting at least 12 weeks before starting another cycle. This gives your hormones, liver, cardiovascular system, and lipid levels time to fully normalize. Skipping this recovery window or cutting it short is one of the most common mistakes, and it compounds the risk of long-term suppression and organ damage with each successive cycle.

Stacking Changes the Math

Running two SARMs simultaneously increases the suppressive load on your endocrine system, which means cycle length should generally be shorter than what you’d run for either compound alone. A common intermediate stack of RAD-140 and LGD-4033 together is typically capped at 8 weeks. The logic is straightforward: two compounds hitting your androgen receptors means faster and deeper suppression, so you compensate by shortening the exposure window.

If you’re new to SARMs entirely, stacking on a first cycle makes it impossible to identify which compound is causing any side effects you experience. Running a single compound for your first cycle, at the shorter end of the recommended range, gives you a baseline for how your body responds.

The Product Quality Problem

All of these cycle guidelines assume you’re actually taking what you think you’re taking. Because SARMs occupy a legal gray area and aren’t manufactured under pharmaceutical oversight, the contents of what you buy can vary wildly from what’s on the label. The FDA has pursued criminal actions against distributors and issued warning letters to companies selling unapproved SARM products. Some products contain different compounds entirely, different doses than listed, or additional unlabeled ingredients. This uncertainty adds an uncontrollable variable to any cycle plan, since you can’t accurately gauge dosing or suppression if the product itself is unreliable.